Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,182
Total Claims
$915K
Drug Cost
335
Beneficiaries
$2,731
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+158%
Opioid rate vs peers
6.7% vs 2.6% avg
+156%
Cost per patient vs peers
$2,731 vs $1,068 avg
+78%
Brand preference vs peers
16.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
6.7%
Opioid Rate
611
Opioid Claims
$32K
Opioid Cost
5.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,463 claims · $764K
Generic: 7,666 claims · $147K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tirzepatide | 63 | $68K |
| Rivaroxaban | 84 | $56K |
| Dapagliflozin Propanediol | 56 | $44K |
| Budesonide/Glycopyr/Formoterol | 59 | $40K |
| Paliperidone Palmitate | 14 | $33K |
| Apixaban | 57 | $32K |
| Fluticasone/Umeclidin/Vilanter | 43 | $32K |
| Mirabegron | 37 | $26K |
| Semaglutide | 15 | $25K |
| Dulaglutide | 25 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $24K |
| Empagliflozin | 29 | $23K |
| Sitagliptin Phosphate | 33 | $19K |
| Atogepant | 13 | $17K |
| Budesonide/Formoterol Fumarate | 41 | $17K |
Prescribing Profile
Patient Profile
71
Avg Age
69%
Female
1.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About